输注滤白血小板对患者HLA抗体产生的影响OA
Effect of leukocyte-reduced platelet transfusion on the production of HLA antibodies in patients
目的 探讨血小板输注患者HLA抗体产生的相关因素及白细胞滤除技术的干预效果.方法 以 2021年 3 月 1 日—2025 年3 月31 日2 518 例输注血小板患者为研究对象,采用固相凝集法检测HLA抗体,分析性别、年龄、血小板输注次数、白细胞滤除操作对HLA抗体产生的影响.结果 性别、年龄、血小板输注次数是HLA抗体产生的独立危险因素,其中女性抗体产生风险比男性高 1.64 倍(OR 1.64,95%Cl 1.31-2.07);对比<18 岁患者,18~60 岁、>60 岁患者抗体产生风险分别降低 35%(OR 0.65,95%Cl 0.50-0.86)、40%(OR 0.60,95%Cl 0.44-0.83);对比血小板输注次数为 1 次患者,输注次数为 2 次、≥3 次患者抗体产生风险分别高 2.02 倍(OR 2.02,95%Cl 1.49-2.74)、14.50 倍(OR 14.50,95%Cl 11.16-18.84);未滤白组 HLA 抗体阳性率为 20.76%,显著高于滤白组14.31%(χ2=12.27,P<0.01),但经多因素校正后,未滤除白细胞不是HLA抗体产生的独立危险因素.将血小板输注次数与白细胞滤除进行交互分析,结果显示:1)输注次数为 2 次时:对比全滤白组,未滤白 1 次组抗体产生风险无统计学差异(P>0.05),未滤白 2 次组抗体产生风险高 1.64 倍(OR 1.64,95%Cl 1.19-2.28);2)输注次数为≥3 次时:对比全滤白组,未滤白 1 次、2 次、3 次组抗体产生风险分别高 25.45 倍(OR 25.45,95%Cl 10.73-60.36)、10.59倍(OR 10.59,95%Cl 5.07-22.14)、11.45 倍(OR 11.45,95%Cl 8.76-14.96).在血小板输注次数为 1 次患者中,与输注医院血库滤白 1 次血小板相比,输注血站滤白血小板患者的HLA抗体产生风险降低 65%(OR 0.35,95%Cl 0.18-0.69);医院血库滤白 2 次组与滤白 1 次组抗体产生风险差异无统计学意义(P>0.05).结论 女性、儿童、血小板输注次数是HLA抗体产生的危险因素,白细胞滤除技术可以降低HLA抗体阳性率,对于有妊娠史的女性、小于18 岁的儿童,输注血小板次数≥3 次的患者首选血站滤白机采血小板输注.
Objective To investigate the factors associated with HLA antibody formation in patients undergoing platelet transfusion and to evaluate the intervention effect of leukocyte depletion technology.Methods The study enrolled 2 518 patients who received platelet transfusions from March 1,2021 to March 31,2025.HLA antibodies were detected using a solid-phase agglutination method.The effects of gender,age,the number of platelet transfusions,and leukocyte depletion on the formation of HLA antibodies were analyzed.Results Gender,age,and the number of platelet transfusions were i-dentified as independent risk factors for HLA antibody formation.Female patients exhibited a 1.64-fold higher risk com-pared to males(OR 1.64,95%CI 1.31-2.07).Compared with patients under 18 years of age,those aged 18-60 and over 60 showed a 35%and 40%reduction in antibody formation risk,respectively(OR 0.65,95%CI 0.50-0.86;OR 0.60,95%CI 0.44-0.83).Compared with patients who received single platelet transfusion,those with 2 and≥3 transfusions were associated with a 2.02-fold and 14.50-fold increased risk,respectively(OR 2.02,95%CI 1.49-2.74;OR 14.50,95%CI 11.16-18.84).The HLA antibody positivity rate was significantly higher in the non-leukocyte-depleted group(20.76%)than in the leukocyte-depleted group(14.31%)(χ2=12.27,P<0.01).However,after multivariate adjust-ment,absence of leukocyte depletion was not an independent predictor of HLA antibody formation.Interaction analysis be-tween the number of transfusions and leukocyte depletion revealed that:1)Among patients receiving 2 transfusions,no sig-nificant difference in antibody formation risk was observed between the group with 1 non-leukocyte-depleted transfusion and the fully depleted group(P>0.05),whereas the group with 2 non-leukocyte-depleted transfusions had a 1.64-fold higher risk(OR 1.64,95%CI 1.19-2.28);2)Among patients receiving≥3 transfusions,the groups with 1,2,and 3 non-leu-kocyte-depleted transfusion exhibited 25.45-,10.59-,and 11.45-fold higher risks,respectively(OR 25.45,95%CI 10.73-60.36;OR 10.59,95%CI 5.07-22.14;OR 11.45,95%CI 8.76-14.96),compared with the fully depleted group.In patients who received 1 platelet transfusion,compared with patients who received platelets filtered by the hospital blood bank,the risk of HLA antibody formation was reduced by 65%(OR 0.35,95%CI 0.18-0.69)in patients who re-ceived platelets filtered by the blood station.There was no statistically significant difference in the risk of antibody formation between the group that received platelets filtered twice by the hospital blood bank and the group that received platelets fil-tered once(P>0.05).Conclusion Female,younger age(under 18),and increased number of platelet transfusions are significant risk factors for HLA antibody formation.Leukocyte depletion effectively reduces the incidence of HLA antibody positivity.For female patients with a history of pregnancy and pediatric patients under 18 years of age,and patients receiv-ing≥3 platelet transfusions,leukocyte-depleted apheresis platelets from the blood station should be the preferred choice.
李霁欣;李少文
南方医科大学珠江医院 输血医学科,广东 广州 510280南方医科大学珠江医院 输血医学科,广东 广州 510280
医药卫生
人类白细胞抗原(HLA)抗体白细胞滤除血小板输注
human leukocyte antigen(HLA)antibodyleukocyte depletionplatelettransfusion
《中国输血杂志》 2026 (3)
323-328,6
评论